- Pharmacokinetics of anti-cancer agents
- Development of novel therapy in gastrointestinal and head/neck cancers
Eric (Xueyu) Chen
PLoS One. 2016;11(12):e0165214
Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial.
JAMA Oncol. 2016 Dec 08;:
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial.
Genome Med. 2016 Oct 25;8(1):109
Phase 1/2 Study of the Addition of Cisplatin to Adjuvant Chemotherapy With Image Guided High-Precision Radiation Therapy for Completely Resected Gastric Cancer.
Int J Radiat Oncol Biol Phys. 2016 Aug 31;:
Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Eur J Cancer. 2016 Sep 23;67:174-182
Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001).
Invest New Drugs. 2016 Jun 11;
A Phase I study of olaparib and irinotecan in patients with colorectal cancer: Canadian Cancer Trials Group IND 187.
Invest New Drugs. 2016 Apr 13;
Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen.
BMC Cancer. 2016;16(1):19
J Neurosurg Spine. 2015 Oct 30;:1-8
Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease.
Cell Host Microbe. 2015 Oct 14;18(4):489-500
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Affiliate Scientist, Princess Margaret Cancer Centre
Assistant Professor, Faculty of Medicine, University of Toronto
Staff Oncologist, Princess Margaret Cancer Centre